Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C

Telaprevir and Boceprevir are the first direct acting antivirals approved for chronic hepatitis C in combination with peg-interferon alfa and ribavirin. Pancytopenia due to myelotoxicity caused by these drugs may occur, but severe hematological abnormalities or aplastic anemia (AA) have not been des...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World J Gastroenterol
Main Authors: Lens, Sabela, Calleja, Jose L, Campillo, Ana, Carrión, Jose A, Broquetas, Teresa, Perello, Christie, de la Revilla, Juan, Mariño, Zoe, Londoño, María-Carlota, Sánchez-Tapias, Jose M, Urbano-Ispizua, Álvaro, Forns, Xavier
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Inc 2015
Assuntos:
Case Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4419084/
https://ncbi.nlm.nih.gov/pubmed/25954117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i17.5421
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados